Intraocular drug delivery. In vitro release studies of 5-fluorouracil from N1-alkoxycarbonyl prodrugs in silicone oil

International Journal of Pharmaceutics

Volumn 132, Issue 1-2, 1996, Pages 243-250

  Steffansen, Bente ^a   Ashton, Paul ^b   Buur, Anders ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NEW ENGLAND EYE CENTER   (United States)

^c H LUNDBECK A S   (Denmark)

Author keywords

5 Fluorouracil; Controlled release; Ocular drug delivery; Prodrugs; Silicone oil 1000

Indexed keywords

FLUOROURACIL DERIVATIVE; PRODRUG; SILICONE OIL;

ARTICLE; CATTLE; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HUMAN; IONIC STRENGTH; IONIZATION; LIPOPHILICITY; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; RABBIT; SUSTAINED RELEASE PREPARATION; VITREOUS BODY;

EID: 0029975363     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04376-4     Document Type: Article

References (18)

1. Albert, A. and Serjeant, E.P., The Determination of Ionization Constants, Chapman and Hall, London, 1971, pp. 44-60.
2. Blumenkranz, M.S., Claflin, A. and Hajek, A.S., Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation. Arch. Opthalmol., 102 (1984a) 598-604.
3. Blumenkranz, M.S., Hernandez, E., Ophir, A. and Norton., E.W.D., 5-Fluorouracil: new applications in complicated retinal detachment for an established antimetabolite. Opthalmology, 91 (1984b) 122-130.
4. British Patent, Number 1 542053, 1977, pp. 1-10.
5. Buur, A. and Bundgaard, H., Prodrugs of 5-fluorouracil V. l-Alkoxycarbonyl derivatives as potential prodrug forms for improved rectal or oral delivery of 5-fluorouracil. J. Pharm. Sci., 75 (1986) 522-527.
6. Capone, A., Scot, J., Lance, E., Friend, J. and Thoft, R.A., In vivo effects of 5-FU on ocular surface epithelium following corneal wounding. Invest. Opthalmol. Vis. Sci., 28 (1987) 1661-1667.
7. Glaser, B.M., Cardin, A. and Biscoe, B., Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction. Opthalmology, 94 (1987) 327-332.
8. Hansch, C. and Leo, A., Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley, New York, 1979, p. 85.
9. Hartzer, M.K. and Blumenkranz, M.S., Fluoropyrimidines in the treatment of vitreoretinopathy and glaucoma. In Tso, M.O.M. (Ed.), Retinal Diseases, Biochemical Foundations and Clinical Management, Lippincott, Philidelphia, PA, 1988, pp. 347-361.
10. Higuchi, T. Rate release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci., 50 (1961) 874-875.
11. Jarus, G., Blumenkranz, M.S., Hernandez, E. and Sossi, N., Clearance of intravitreal fluorouracil. Opthalmology, 92 (1985) 91-96.
12. Leon, J.A., Britt, J.M., Hopp, R.H., Mills, R.P. and Milam, A.H., Effects of fluorouracil and fluorouridine on protein synthesis in rabbit retina. Invest. Opthalmol. Vis. Sci., 31 (1990) 1709-1716.
13. Lucke, K. and Laqua, H., Silicone Oil in the Treatment of Complicated Retinal Detachment. Techniques, Results and Complications, Springer, Berlin, 1990, pp. 1-161.
14. Machmer, R., Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Invest. Opthalmol. Vis. Sci., 29 (1988) 1771-1783.
15. 14C-fluorouracil in rabbits. Arch Opthalmol., 97 (1979) 2375-2378.
16. Steffansen, B., Brown, J.D., Ashton, P. and Buur, A., 5-Fluorouracil prodrugs in a lipophilic membrane as sustained release system. Pharm. Res. 8 (1991) S192.
17. Steffansen, B., Pearson, P.A., Buur, A. and Ashton, P., Alkoxycarbonyl prodrugs of 5-fluorouracil suspended in silicone oil as an intraocular sustained release system. Pharm. Res., 9 (1992) S237.
18. Stern, W., Geoffrey, L.P., Erickson, P., Guerin, G., Anderson, D., Fisher, S. and O'Donnell, J. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am. J. Opthalmol. 96 (1983) 33-42.